Market Overview - The market experienced fluctuations with mixed performance across the three major indices. The Shanghai Composite Index fell by 0.39%, while the Shenzhen Component Index rose by 0.26%, and the ChiNext Index decreased by 0.75% [1] - The total trading volume in the Shanghai and Shenzhen markets was 2.68 trillion yuan, a decrease of 462.1 billion yuan compared to the previous trading day [1] - Sectors such as pork, gaming, consumer electronics, and beauty care saw significant gains, while sectors like CRO, rare earth permanent magnets, PEEK materials, and military industry faced declines [1] Foreign Capital Inflow - Huatai Securities reported that active foreign capital recorded its first net inflow of the year, with over 90 billion yuan in financing inflows last week, marking the highest activity level since 2016 [2] - Since the end of June, new public offerings have been recovering, with nearly 20 billion new public fund shares issued last week, and over 50 equity fund reports released, showing a month-on-month increase [2] - Active foreign capital positions in A-shares have returned to the mid-levels seen since 2021, indicating potential for further accumulation [2] REITs Market Outlook - Citic Construction Investment believes that the REITs market has reached a turning point and is optimistic about a stabilization and rebound, with potential for new highs this year [3] - After a two-month correction, the market has stabilized, with a 1.75% increase over the last five trading days [3] - The report highlights that three short-term negative factors are nearing exhaustion, while three long-term positive factors remain unchanged, suggesting an acceleration of capital inflow into REITs [3] Chinese Innovative Pharmaceuticals - Guojin Securities stated that Chinese innovative pharmaceuticals are achieving comprehensive success, with ADC and dual/multi-antibody technologies leading globally, and the number of pipelines ranking first worldwide [4] - In 2023, the value of license-out deals has surpassed that of license-in deals for the first time, with record-breaking amounts and significant interest from overseas multinational corporations [4] - The report emphasizes the supportive policies across the entire chain, including procurement clearance, regulatory reviews, and insurance, contributing to marginal performance improvements [4]